Effect of dry period length on the effect of an intramammary teat sealant on the risk of mastitis in cattle treated with antibiotics at drying off

AIM: The aim of this study was to evaluate, under farm conditions, the use of a teat sealant in addition to whole herd dry cow antibiotic therapy on the risk of clinical mastitis in dairy cattle at pasture, and to evaluate the impact of dry period length on that risk and the impact of the teat sealant on that risk.

METHODS: Dairy cows in three herds which used routine whole herd antibiotic therapy were randomly assigned to receive either treatment with an internal teat sealant (n=322) or no additional treatment (n=313) at drying-off between March and May 2010. All clinical mastitis cases during the dry period and to the end of the subsequent lactation were recorded by farm staff; factors affecting risk of clinical mastitis were then analysed using a Cox proportional hazards model.

RESULTS: Median duration of the dry period was 112 days with >25% of cows having a dry period >130 days. The incidence risk of mastitis during lactation for cows treated with teat sealant was 9.9 (95% CI=6.9–13.7) cases per 100 cows compared with 17.9 (95% CI=13.8–22.6) cases per 100 cows for cows treated with antibiotic alone. The addition of a teat sealant to dry cow antibiotic therapy decreased the risk of clinical mastitis only in the first 33 days after calving (Hazard risk 0.24 (95% CI=0.12–0.48)). Length of dry period did not significantly affect the risk of clinical mastitis, or the effect of adding teat sealant to dry cow antibiotic therapy on the risk of clinical mastitis.

CONCLUSIONS: In these herds where, based on the mastitis history, whole herd antibiotic therapy had been recommended, the use of a teat sealant significantly reduced the risk of clinical mastitis. This effect was limited to the first 33 days after calving; subsequently there was no significant effect of treatment. There was no effect of dry period length on risk of clinical mastitis, nor any significant interaction with treatment.

CLINICAL RELEVANCE: Combination therapy with teat sealant and antibiotic was effective under New Zealand conditions in herds using whole herd antibiotic treatment at drying off. Teat sealant reduced risk of clinical mastitis in cattle with dry periods substantially longer than 100 days, and there was no evidence that this effect changed as dry period length increased.     

中国荷斯坦牛乳房炎风险评估模型建立及预测分析

实验旨在探究奶牛乳房炎的风险因素,建立奶牛乳房炎风险评估模型,预测奶牛乳房炎患病风险。本研究利用北京地区1998—2016年196万余条奶牛群体改良(Dairy Herd Improvement,DHI)测定记录,将具有统计学意义的因素进行多因素Logistic回归分析,分析其中的风险因素,并建立奶牛乳房炎风险评估模型,通过大量DHI记录进行奶牛乳房炎患病风险预测研究。多因素Logistic回归分析结果发现,场规模越大,奶牛患乳房炎的概率相对越小;胎次越高,奶牛患乳房炎的概率越大;夏季奶牛患乳房炎的概率比其他季节的概率高;泌乳天数高于300 d的奶牛患乳房炎风险约为泌乳天数低于100 d奶牛的2倍。使用北京地区DHI记录进行Logistic回归分析得出,奶牛隐性乳房炎风险评估模型和奶牛临床乳房炎风险评估模型预测价值分别为0.721和0.825,认为可以应用于实际牛群。综上,本研究中确定的奶牛场规模、胎次、DHI测定季节、泌乳阶段等风险因素可用于奶牛乳房炎预测,并构建了奶牛隐性乳房炎、临床乳房炎的风险评估模型,以减少奶牛群的乳房炎发生概率。     

Intramammary application of ozone therapy to acute clinical mastitis in dairy cows

The infusion of ozone into the inflamed quarter of cows with clinical mastitis was performed and the efficacy of ozone therapy was evaluated. Ozone was infused into the inflamed quarter via a teat canal using ozone gas generating equipment. Nineteen Holstein cows with acute clinical mastitis were divided into two groups: 15 cows treated with ozone therapy, and 4 cows treated with antibiotic therapy. Systemic and local clinical signs, California Mastitis Test scores, the mastitis causing pathogens, electronic conductivity of milk, and somatic cell counts in milk from ozone- and antibiotic-treated quarters, were compared between the groups. Sixty percent (9/15) of cows with acute clinical mastitis treated with ozone therapy, did not require any antibiotics for recovery. This newly developed ozone therapy method was proven to be effective, safe, and cost effective, and carries no risk of drug residues in milk.     

Quarter-milking-, quarter-, udder- and lactation-level risk factors and indicators for clinical mastitis during lactation in pasture-fed dairy cows managed in an automatic milking system

Objectives To identify risk factors and indicators at quarter‐milking and other levels for clinical mastitis during lactation in pasture‐fed cows managed in an automatic milking system. Design A retrospective nested case–control study using data collected over a 31‐month period. A total of 803,948 quarter‐milkings from 249 cows were available for analysis, of which 245 were selected as clinical mastitis quarter‐milking cases and 2450 unaffected quarter‐milkings were selected as controls. Most of the diagnoses of clinical mastitis had been made after clinical assessments of quarters following automated alerts by the milking system. Potential risk factors and indicators were assessed using univariable and multivariable multilevel logistic models. Results Quarters that are milked infrequently and have low yield, fast peak milk flow rates, blood in the milk and/or elevated milk conductivity are at increased risk of clinical mastitis. Quarters were also at increased risk between days 10 and 29 of lactation, and during higher parity lactations. Milk fat and protein concentrations and the fat : protein ratio were not significantly associated with the development of clinical mastitis. Neither quarter position (fore or rear) nor side (left or right) was associated with clinical mastitis occurrence. Quarters that had been clinically affected more than 30 days previous in the current lactation were not at increased risk of redeveloping clinical mastitis. Conclusions Under the study conditions, the risk of clinical mastitis increased for quarter‐milkings in quarters that were milked less frequently in the previous 7 days, were low‐yielding, had fast peak milk flow rates and had more milkings in which blood was detected in milk and/or the milk conductivity was elevated. Risk was also increased in days 10–29 of lactation and in higher parity lactations.     

Managerial and environmental determinants of clinical mastitis in Danish dairy herds

Background

Several management and environmental factors are known as contributory causes of clinical mastitis in dairy herd. The study objectives were to describe the structure of herd-specific mastitis management and environmental factors and to assess the relevance of these herd-specific indicators to mastitis incidence rate.

Methods

Disease reports from the Danish Cattle Data Base and a management questionnaire from 2,146 herds in three Danish regions were analyzed to identify and characterize risk factors of clinical mastitis. A total of 94 (18 continuous and 76 discrete) management and production variables were screened in separate bivariate regression models. Variables associated with mastitis incidence rate at a p-value < 0.10 were examined with a factor analysis to assess the construct of data. Separately, a multivariable regression model was used to estimate the association of management variables with herd mastitis rate.

Results

Three latent factors (quality of labor, region of Denmark and claw trimming, and quality of outdoor holding area) were identified from 14 variables. Daily milk production per cow, claw disease, quality of labor and region of Denmark were found to be significantly associated with mastitis incidence rate. A common multiple regression analysis with backward and forward selection procedures indicated there were 9 herd-specific risk factors.

Conclusion

Though risk factors ascertained by farmer-completed surveys explained a small percentage of the among-herd variability in crude herd-specific mastitis rates, the study suggested that farmer attitudes toward mastitis and lameness treatment were important determinants for mastitis incidence rate. Our factor analysis identified one significant latent factor, which was related to labor quality on the farm.     

Efficacy of blanket treatment of cows and heifers with an internal teat sealant in reducing the risk of mastitis in dairy cattle calving on pasture

AIM: To evaluate the benefit of blanket treatment of all milking cows at drying-off and all replacement heifers one month prior to the planned start of mating with an internal teat sealant on the incidence of mastitis, and somatic cell counts (SCC), postpartum in a 650-cow herd with a mastitis incidence in early lactation of 15% in cows and 26% in heifers. METHODS: Prior to drying-off, lactating cattle were divided on the basis of SCC and mastitis history. Cattle with records of individual SCC >150,000 cells/ml or mastitis in the previous lactation were treated with a cloxacillin-based dry-cow therapy (DCT), while the remaining cattle received no antibiotics. Cattle in each of the two groups were then randomly assigned to receive either an internal teat sealant or no further treatment. Additionally, one month prior to the planned start of calving the rising 2-year-old heifers were also randomly assigned to receive either an internal teat sealant or no treatment. All clinical mastitis cases were recorded for the first 10 weeks after the start of calving, while SCC were measured on three occasions during the subsequent lactation. RESULTS: Data were available from 466 cows and 206 heifers; treatment with the internal teat sealant significantly reduced the incidence of mastitis in both groups. For cows, the reduced risk of mastitis due to treatment with the teat sealant was not significantly different between cows, which, based on their mastitis history, required dry-cow antibiotics and those which did not. There was no effect of teat sealant on the mean SCC of any group at any time-point. CONCLUSIONS: On this farm, treatment of all cows and heifers prior to parturition with an internal teat sealant significantly reduced the risk of clinical mastitis. The benefits of an internal teat sealant were the same when used in combination with antibiotics in cows with a history of mastitis as when used alone in cows with no such history. CLINICAL RELEVANCE: These data support the proposition that blanket treatment with an internal teat sealant of all cows due to enter the milking herd can be a useful method of mastitis control. They also suggest that combined therapy with dry-cow antibiotics and internal teat sealants can be beneficial under New Zealand conditions. More detailed research on more farms in more areas of New Zealand is required to confirm these suggestions.     

Ecologic study of the risk factors for environmental mastitis in cows

An index was developed to measure the proportion of intramammary infections caused by environmental microorganisms on dairy farms. This environmental index can be interpreted as the probability that an intramammary infection was caused by an environmental pathogen, rather than by a contagious pathogen. Using the environmental index as the outcome variable, risk factors for environmental mastitis were studied on 10 dairy farms in New York. Turning the cows outside was associated with lower environmental index, and having cows drink from a stream increased the environmental index. Selective (rather than uniform) nonlactating cow intramammary treatment was related to a lower environmental index (apparently because the farms practicing selective nonlactating cow treatment suffered from epizootics of contagious mastitis).     

Risk Factors for Dairy Cow Mastitis in the Central Highlands of Ethiopia

This study, with the objective of assessing the effect of risk factors on dairy cow mastitis in the central highlands of Ethiopia, was undertaken between February and September 2001 in the urban and peri-urban areas of Addis Ababa, Ethiopia. A prevalence study and questionnaire survey were carried out simultaneously. Clinical examination of lactating udders and California mastitis test (CMT) determined clinical and subclinical mastitis, respectively. Risk factors for subclinical and clinical mastitis were identified from data on animals and farm management by chi-square analysis and subsequent logistic regression. Cows aged at least 8 years, with poor body condition, with at least 8 parities and in at least the eighth month of lactation had a significantly higher risk for subclinical mastitis (p < 0.05). The risk was reduced for cows up to their third parity in good body condition and for cows receiving dry cow therapy. Cows aged at least 4 years, or with at least 8 parities, cows in at least the fourth month of lactation, cows with poor body condition, leaking milk or previous udder infections had a significantly higher risk of clinical mastitis (p <0.05). The risk was reduced by the use of separate towels for udder cleaning and by drying off at the end of lactation. Most of the risk factors were in agreement with previous reports. However, stage of lactation and drying-off style were in contrast to others. Further research is needed to identify the interrelationship between production level, specific pathogens and management risk factors.     

Prevalence of clinical mastitis in 38 Waikato dairy herds in early lactation

AIM: To determine the prevalence of clinical mastitis in spring-calving dairy herds in the Waikato Region of New Zealand and to identify factors associated with variation in the prevalence of clinical mastitis between herds. METHOD: A total of 799 quarters from 595 dairy cows from 38 dairy herds were diagnosed by herd owners as having clinical mastitis between 8 July and 21 August 1997. Quarters diagnosed with clinical mastitis were sampled for bacterial culture and somatic cell count, and the presence of clots in the milk and the presence of udder oedema were assessed by a technician or veterinarian. RESULTS: Clinical mastitis was diagnosed in an average (+/-s.e.m.) of 9.9% (+/-0.8%, range 0.9-21.4%) of calved cows within the herds. Bacteria were not cultured from an average of 12.4 % (+/- 2.0%, range 0.0-45.5%) of cows and 22.3% (+/- 2.4%, range 0.0-54.0%) of quarters diagnosed as having clinical mastitis. There were significant differences between herds in the proportion of cows diagnosed with mastitis and in the proportion of clinical mastitis cases from which bacteria were not cultured. A decreased prevalence of clinical mastitis (p<0.001) was associated with an increased percentage of the herd treated with dry cow antibiotics. An increased prevalence of clinical mastitis (p<0.0001) was associated with both an increased percentage of cows treated in the previous season with lactating cow antibiotics and an increased percentage of heifers in the herd. Herds that were fed supplements before or during lactation had a higher prevalence of clinical mastitis than herds that were not fed supplements (p<0.001). An increased proportion of quarters diagnosed with clinical mastitis that did not culture bacteria was associated with an increased prevalence of clinical mastitis (p<0.001). The proportion of quarters that the technician or veterinarian found with evidence of clinical mastitis (i.e. a somatic cell count >500,000 cells/ml and the presence of either clots or udder oedema) within a herd was inversely related to the proportion of quarters within a herd from which no bacteria were isolated. CONCLUSION: There was a large variation in the prevalence of clinical mastitis and in the proportion of clinical quarters from which no bacteria were grown between herds. Management factors such as the use of dry cow therapy, feeding regimes and heifer replacement rates all affected the prevalence of clinical mastitis. Herd owners appear to differ in the sensitivity and specificity of their diagnosis of clinical mastitis, with bacteria not isolated from up to 50% of quarters diagnosed with clinical mastitis in some herds. Improvements in the specificity of herd owner diagnosis of clinical mastitis may reduce the use of antibiotics for mastitis during lactation and hence may reduce the risk of antibiotic contamination of milk supplied for human consumption.     

Evaluation of stratification factors and score-scales in clinical trials of treatment of clinical mastitis in dairy cows

There is often a need to reduce sample size in clinical trials due to practical limitations and ethical considerations. Better comparability between treatment groups by use of stratification in the design, and use of continuous outcome variables in the evaluation of treatment results, are two methods that can be used in order to achieve this. In this paper the choice of stratification factors in trials of clinical mastitis in dairy cows is investigated, and two score-scales for evaluation of clinical mastitis are introduced. The outcome in 57 dairy cows suffering from clinical mastitis and included in a clinical trial comparing homeopathic treatment, placebo and a standard antibiotic treatment is investigated. The strata of various stratification factors are compared across treatments to determine which other factors influence outcome. The two score scales, measuring acute and chronic mastitis symptoms, respectively, are evaluated on their ability to differentiate between patients classified from clinical criteria as responders or non-responders to treatment. Differences were found between the strata of the factors severity of mastitis, lactation number, previous mastitis this lactation and bacteriological findings. These factors influence outcome of treatment and appear relevant as stratification factors in mastitis trials. Both score scales differentiated between responders and non-responders to treatment and were found useful for evaluation of mastitis and mastitis treatment.     

The use of Markov chain Monte Carlo for analysis of correlated binary data: patterns of somatic cells in milk and the risk of clinical mastitis in dairy cows

Two analytical approaches were used to investigate the relationship between somatic cell concentrations in monthly quarter milk samples and subsequent, naturally occurring clinical mastitis in three dairy herds. Firstly, cows with clinical mastitis were selected and a conventional matched analysis was used to compare affected and unaffected quarters of the same cow. The second analysis included all cows, and in order to overcome potential bias associated with the correlation structure, a hierarchical Bayesian generalised linear mixed model was specified. A Markov chain Monte Carlo (MCMC) approach, that is Gibbs sampling, was used to estimate parameters.

The results of both the matched analysis and the hierarchical modelling suggested that quarters with a somatic cell count (SCC) in the range 41,000–100,000 cells/ml had a lower risk of clinical mastitis during the next month than quarters <41,000 cell/ml. Quarters with an SCC >200,000 cells/ml were at the greatest risk of clinical mastitis in the next month. There was a reduced risk of clinical mastitis between 1 and 2 months later in quarters with an SCC of 81,000–150,000 cells/ml compared with quarters below this level. The hierarchical modelling analysis identified a further reduced risk of clinical mastitis between 2 and 3 months later in quarters with an SCC 61,000–150,000 cells/ml, compared to other quarters.

We conclude that low concentrations of somatic cells in milk are associated with increased risk of clinical mastitis, and that high concentrations are indicative of pre-existing immunological mobilisation against infection. The variation in risk between quarters of affected cows suggests that local quarter immunological events, rather than solely whole cow factors, have an important influence on the risk of clinical mastitis. MCMC proved a useful tool for estimating parameters in a hierarchical Bernoulli model. Model construction and an approach to assessing goodness of model fit are described.     

草坪草病害风险性评估体系的初步建立及应用

为探索建立统一的草坪草病害风险性评价尺度，本研究引入有害生物风险分析（Pest Risk Analysis）理论。基于有害生物风险分析的规定程序，结合草坪绿地生态系统特点及模糊数学理论，利用德尔菲法及层次分析法，探讨了草坪绿地病害风险分析体系的建立、评价指标和评价值的计算方法。初步建立了三层次17个评价指标的综合评价模型R=5P1×P2×P3×P4×P5，并运用此模型评价了草坪草5种主要病害的风险性危害值。结果表明，草坪草褐斑病(Rhizoctonia solani)、腐霉病(Phythium ultimum)和镰刀菌枯萎病(Fusarium spp.)3种病害的风险性危害值在0.6～0.8，风险级别为高风险；草坪草锈病(Puccinia spp.)和德氏霉叶枯病(Drechslera spp.)2种病害的风险性危害值在0.4～0.6，风险级别为中等风险。在实际工作中，应根据不同的病害风险等级制定相对应的风险管理策略及具体办法。     

自拟中药方剂治疗奶牛乳房炎的临床效果

[目的]为探讨自拟中药方剂治疗奶牛乳房炎的临床效果。[方法]将辖区内发生乳房炎的奶牛30头作为研究对象,随机分为3组,各10头,A组给予常规西药治疗,B组给予自拟中药方剂治疗,C组给予中西医结合治疗,观察3组病牛的疗效。[结果]A组病牛治疗后临床总有效率为60.00%,B组为80.00%,C组为100.00%,组间差异具有统计学意义(P0.05),提示中西医结合治疗奶牛乳房炎可取得更理想的治疗效果,C组病牛症状消失时间、痊愈时间和复发率均明显少于其余两组,组间差异具有统计学意义(P0.05)。[结论]使用常规西药联合自拟中药方剂治疗奶牛乳房炎疗效明显,缩短病牛康复时间,降低复发率,效果显著,可推广使用。     

Management of dairy heifers and its relationships with the incidence of clinical mastitis

AIM: To describe aspects of management of dairy heifers before calving and determine risk factors for clinical mastitis postpartum in heifers, at the herd level, under pasture-based management systems in the Waikato and Taranaki regions of New Zealand. METHODS: Dairy herdowners (n=578) provided information via a prospective survey about their practices for rearing heifers and management of mastitis. A proportion of herdowners (n=250) subsequently provided data on the cases of clinical mastitis in their herds, including the date, cow identification, age and quarter affected from cases occurring in the 4 months after the planned start of calving (PSC) in the subsequent lactation. The relationship between management factors and the proportion of heifers diagnosed with clinical mastitis within a herd was examined using bivariate and multivariate analyses. RESULTS: The herd average percentage of heifers with clinical mastitis was 13.6 (95% confidence interval (CI)=12.3-14.9)%, and multiparous cows with clinical mastitis was 9.0 (95% CI=8.2-9.8)% in the first 4 months of lactation. There were positive relationships between the proportion of heifers with clinical mastitis and average milk production per cow (kg milksolids/ lactation; p<0.001), number of cows milked per labour unit (p=0.003), stocking rate (<> 3.30 cows/ha; p=0.002), and incidence of clinical mastitis in multiparous cows (%/120 days; p<0.04), in the final multivariate model. The proportion of heifers with clinical mastitis per herd was lower in herds that milked their lactating cows in multiple groups (p=0.02). CONCLUSIONS: The risk of clinical mastitis in heifers was significantly associated with management practices. It may be possible to reduce the incidence of clinical mastitis in heifers by modification of management practices at the herd level, and further studies are required to investigate this.     

Tramped teats--clinical mastitis disease complex in tied cows. Environmental risk factors and interrelationships with other diseases

The effects of stall length, manure system, type of bedding and calving disorders on incidence rates of tramped teats, udder injuries, and clinical mastitis in Swedish Red and White tied cows, as well as interrelationships between these 3 disorders were investigated. Data used consisted of 370 herds, for a total of 45,133 cow records. Cows in herds with liquid manure system were at higher risk of udder injuries and mastitis than in herds with solid system. Lower risk of both udder injuries and mastitis was found for cows in herds with short stall size (less than 180 cm) compared to herds with stalls of 205-219 cm length. It was suggested that other factors, such as slipperiness of the stall floor and presence and type of feeding barrier, must be considered when the effect of stall characteristics on tramped teats is investigated. In farms with solid manure system cut straw or sawdust bedding increased the risk of tramped teats and mastitis relative to uncut straw. Parity and calving disorders were important risk factors for udder health and their effect was greater in herds with liquid manure system. Tramped teats and udder injuries were the most serious risk factors for clinical mastitis.     

A benefit to cost analysis of the effect of premilking teat hygiene on somatic cell count and intramammary infections in a commercial dairy herd.

A field trial was conducted to determine the effect of premilking teat disinfection (predipping) on several measures of mastitis in a commercial dairy farm where the predominant organisms isolated from intramammary infections were coagulase negative Staphylococcus spp. Cows were randomly assigned to a treated (predipped with 0.5% iodine germicide plus "good udder preparation") or a control group ("good udder preparation" alone). Sterile composite milk samples were collected at the initiation of the trial and on an approximately bimonthly basis throughout the duration of the trial. There was no difference in the prevalence of isolation of coagulase-negative Staphylococcus spp. from composite milk samples obtained during the 6 herd cultures. The incidence rate for clinical mastitis in the control group was 1.38 cases per 1000 cow days. The incidence rate for clinical mastitis in the treatment group was 1.06 cases per 1000 cow days. The ratio of these 2 was 1.3, suggesting a higher rate in the control group, but the ratio was not statistically significant (P = 0.34). Logistic regression analysis indicated that the effect of treatment group was not significant, although the coefficient suggested that predipping reduced the risk of clinical mastitis. The benefit to cost ratio of 0.37 indicated that the benefit of reduced incidence of clinical cases of mastitis would not have justified the added expense required to predip the herd.     

Prevalence of Mastitis and Brucellosis in Cattle in Awassa and the Peri‐Urban Areas of Two Smaller Towns

The prevalence of mastitis and brucellosis in urban and peri‐urban settings was studied in Awassa and two smaller nearby towns in southern Ethiopia, because milk‐born diseases are causing a risk for human health, besides direct impacts on animal production. Mastitis was investigated by examining 80 cows (320 udder quarters) using California mastitis test (CMT) and somatic cell count (SCC). The prevalence of brucellosis was assessed by sampling 177 cattle in Awassa and its peri‐urban areas using serological methods. Logistic regression was used to analyse risk factors associated with mastitis. Prevalence of clinical mastitis on quarter level was 0.9%, and 1.9% of quarters were non‐functional or blocked. Prevalence of sub‐clinical mastitis at quarter level in urban and peri‐urban areas was significantly different (P < 0.05). Cows in large herds and at advanced lactation number were associated with higher risk of infection. The percentage of quarters positive on CMT (42.5%) was close to the percentage‐positive detected by SCC (41.2%). Prevalence of brucellosis was 3.9% in the peri‐urban area, while no brucellosis cases were detected in Awassa. More frequent use of artificial insemination in the urban than in peri‐urban area might have contributed to the absence of brucellosis in the urban location. The extent of mastitis is, however, a threat to the dairy enterprise in and around Awassa. Pasteurization of milk and milk products is indicated in some parts of the area because of the danger of brucellosis.     

The influence of laterality on mastitis incidence in dairy cattle--preliminary study

During summer (June to August) of continental weather conditions treated mastitis episodes at a large Hungarian dairy farm were studied to determine the relationship between the distribution of mastitis among quarters of the udder and the lying behaviour (laterality) of the cows. There was a significant difference in laterality between cows that developed mastitis and cows that did not. Cows that developed mastitis, had an increased left laterality in lying, which was related to the increased probability of a right-sided mastitis episode. However, the effect was not significant due to the large variation in the data. At the same time, significantly more cows with clinical mastitis had a somatic cell count (SCC) higher than that of cows without clinical mastitis. While a significant correlation was found between the occurrence of treated mastitis cases and SCC > 1,000,000, no statistically significant differences could be observed in milk production between the two groups.     

Mycoplasma bovis infections in Swiss dairy cattle: a clinical investigation

Mycoplasma bovis causes mastitis in dairy cows and is associated with pneumonia and polyarthritis in cattle. The present investigation included a retrospective case–control study to identify potential herd-level risk factors for M. bovis associated disease, and a prospective cohort study to evaluate the course of clinical disease in M. bovis infected dairy cattle herds in Switzerland. Eighteen herds with confirmed M. bovis cases were visited twice within an average interval of 75 d. One control herd with no history of clinical mycoplasmosis, matched for herd size, was randomly selected within a 10 km range for each case herd. Animal health data, production data, information on milking and feeding-management, housing and presence of potential stress- factors were collected. Composite quarter milk samples were aseptically collected from all lactating cows and 5% of all animals within each herd were sampled by nasal swabs. Organ samples of culled diseased cows were collected when logistically possible. All samples were analyzed by real-time polymerase chain reaction (PCR). In case herds, incidence risk of pneumonia, arthritis and clinical mastitis prior to the first visit and incidence rates of clinical mastitis and clinical pneumonia between the two visits was estimated. Logistic regression was used to identify potential herd-level risk factors for M. bovis infection. In case herds, incidence risk of M. bovis mastitis prior to the first visit ranged from 2 to 15%, whereas 2 to 35% of the cows suffered from clinical pneumonia within the 12 months prior to the first herd visit. The incidence rates of mycoplasmal mastitis and clinical pneumonia between the two herd visits were low in case herds (0–0.1 per animal year at risk and 0.1-0.6 per animal year at risk, respectively). In the retrospective-case-control study high mean milk production, appropriate stimulation until milk-let-down, fore-stripping, animal movements (cattle shows and trade), presence of stress-factors, and use of a specific brand of milking equipment, were identified as potential herd-level risk factors. The prospective cohort study revealed a decreased incidence of clinical disease within three months and prolonged colonization of the nasal cavity by M. bovis in young stock.     

A field study evaluation of Petrifilm™ plates as a 24-h rapid diagnostic test for clinical mastitis on a dairy farm

Clinical mastitis is one of the most common and expensive diseases of dairy cattle. To make an informed treatment decision, it is important to know the causative pathogen. However, no detection of bacterial growth can be made in approximately 30% of all clinical cases of mastitis. Before selecting the treatment regimen, it is important to know whether the mastitis-causing pathogen (MCP) is Gram-positive or Gram-negative. The aim of this field study was to investigate whether using two 3M Petrifilm™ products on-farm (which conveys a higher degree of sample freshness but also bears a higher risk for contamination than working in a lab) as 24-h rapid diagnostic of clinical mastitis achieved results that were comparable to the conventional microbiological diagnostic method.